Saving changes...

Done

Error

Manipulation of Gut Microbiota and GI Motility for Treatment and Prevention of SIBO

Manipulation of Gut Microbiota and GI Motility for Treatment and Prevention of SIBO

Manipulation of Gut Microbiota and GI Motility for Treatment and Prevention of SIBO

Carmelo Scarpinato, MD, DSc, PharmD, MPH, FRCP (Lond), FACP, FCP, FACG, AGAF
Carmelo Scarpinato, MD, DSc, PharmD, MPH, FRCP (Lond), FACP, FCP, FACG, AGAF
on behalf of National University of Health Sciences

$40.00 $ 40.00 $ 40.00

$40.00 $ 40.00 $ 40.00

$ 40.00 $ 40.00 $ 40.00
$ 40.00 $ 40.00 $ 40.00
Normal Price: $40.00 $40.00

Review:

Launch date: 19 Apr 2017
Expiry Date:

Last updated: 12 Jan 2018

Reference: 180479

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

SIBO is a challenging clinical condition. Its etiology is usually complex and multifactorial and the syndrome is often misdiagnosed and generally under-diagnosed. Clinical symptoms may be subtle and non-specific, which makes diagnosis difficult without objective testing. The availability of poorly absorbed antimicrobials (i.e. rifaximin) as well as effective pre- and probiotics has been an advance in treatment, which needs to be refined to identify the best dose and duration to maximize eradication and prevent recurrence. Stimulating GI motility will restore the housekeeping intestinal activity and - by this means - SIBO can be treated and its recurrence prevented.

Objectives

Carmelo Scarpinato, MD, DSc, PharmD, MPH, FRCP (Lond), FACP, FCP, FACG, AGAF

Author Information Play Video Bio

Carmelo Scarpinato, MD, DSc, PharmD, MPH, FRCP (Lond), FACP, FCP, FACG, AGAF
on behalf of National University of Health Sciences

Carmelo Scarpignato graduated in Biochemistry at the University of Messina, and in Medicine and Surgery at the University of Modena in Italy. He is currently Professor of Pharmacology & Therapeutics at University of Parma, Medical School and Associate Professor of Gastroenterology at University of Nantes. He is also Consultant Clinical Pharmacologist at Maggiore University Hospital in Parma. He has been Visiting Professor at some prestigious European and USA Universities.

Professor Scarpignato’s main research interests focus on digestive clinical pharmacology, gastrointestinal motility, and upper GI pathophysiology. He has authored 560 publications (of which 330 are full papers or book chapters) on these topics and has also edited 28 books on clinical evaluation of GI function and on Pharmacology & Therapeutics of Digestive Diseases. He is or has been on the editorial boards of Pharmacology, Gut, Digestion, Digestive Diseases, Current Gastroenterology Reports, Alimentary Pharmacology & Therapeutics, BMC Gastroenterology, BMC Medicine, World Journal of Gastroenterology, American Journal of Pharmacology & Therapeutics, Therapeutic Advances in Drug Safety and Current Clinical Pharmacology, amongst others. He is also a Section Editor (GI and Liver Pharmacology) of Fundamental and Clinical Pharmacology and of Gastroenterology International, and has been co-Editor of two prestigious book series, Frontiers of Gastrointestinal Research and Progress in Basic and Clinical Pharmacology.

Professor Scarpignato is a Fellow of the Royal College of Physicians (London), The American College of Physicians, the American College of Clinical Pharmacology, the American College of Gastroenterology and of the American Gastroenterological Association. In addition, he is a member of several national and international scientific societies, including the British Pharmacological Society and the American Society for Pharmacology and Experimental Therapeutics (ASFET). He is presently the Secretary General of the World Organization for Specialized Studies on Diseases of the Esophagus (OESO) and Governor for Italy of the American College of Gastroenterology (ACG). His biography has been included into the 2009-2010 Edition of Who’s Who in Medicine and Healthcare.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

Faculty and Disclosures

Additional Contributors

Chiropractic Continuing Education credits:
This course is valid for continuing education credit in the following states, so long as it falls within the scope of practice as outlined by the corresponding state board(approval numbers provided for states which require them):
AL (700106), AK (3680),CA (CA-A-17-01-13108 principles of practice),CO, CT, DE, DC, GA,HI(17-040) ID, IL, IA, KS, MN (3680), MD, MI, MT, ND(3680) NE, NH, NJ (3680), NM, NY (705), NV (3680), OH, OR, PA(DCE000502), RI, SC, SD(3680), TN(3680), UT, VT, VA, WA, WV

Please note that online continuing education is not recognized in the following states:
FL, IN, KY, LA, MS, OK, WI, WY

Naturopathic Continuing Education:
OR (0.5 General, 0.5 Pharmacy)


If your state is not listed, please check approved continuing education through your respective state board, or contact our offices.


NUHS makes no representation either directly or indirectly that the substantive matter being presented is approved or within respective scope of licensing. It remains the attendees' responsibility to contact the state board(s) from which they seek continuing education credits for purposes of ensuring said board(s) approves both the delivery method and content as they relate to this event.

postgrad@nuhs.edu | (630) 889-6622

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error